Equine sarcoid tumour treated by autogenous tumour vaccine.
Twenty-one horses with sarcoid tumours were treated by bio-immunotherapy using autogenous vaccines during 1991-1997. At operation the base of the tumour was left in the skin and autovaccines were made from extirpated tumour tissue by polymerization. The horses thus formed their own internal control group. One of 12 horses having a primary tumour, and four of 9 horses suffering recurrent tumours, prior to bio-immunotherapy, developed single recurrences. Four of these five horses suffering recurrence were treated anew, leading to remission. Disease-free intervals were longer for primary (P = 0.0005) and recurrent sarcoids (P = 0.0156) than for conventional surgery alone. Mitochondrial events seem to effect the healing.
Kinnunen
R E
RE
Veterinary Clinic, Nummela, Finland.
Tallberg
T
T
Stenbäck
H
H
Sarna
S
S
D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D006734:Horse Diseases / Q000473:pathology / Q000628:therapy*; D006736:Horses; D015552:Injections, Intralesional / Q000662:veterinary; D008297:Male; D008854:Microscopy, Electron; D012008:Recurrence; D012509:Sarcoma / Q000473:pathology / Q000628:therapy* / Q000662:veterinary*; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy* / Q000662:veterinary*
D019496:Cancer Vaccines